

HY-158049 · 50 mg
MedChemExpress · Cat: HY-158049
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/anticancer-agent-199.html
Description
Anticancer agent 199 Compound G-4 induces apoptosis in triple negative breast cancer TNBC cells via the mitochondrial pathway through inhibiting EGFR, AKT and MAPK pathways. Anticancer agent 199 also induces Ferroptosis by down-regulating LCN2. Anticancer agent 199 inhibits TNBC cell viability and migration, and induces S phase cell cycle arrest. Anticancer agent 199 is a derivate of cyclin-dependent kinase inhibitor Rocovitine.







